Sickle-cell disease

The Lancet

Volumn 376, Issue 9757, 2010, Pages 2018-2031

  Rees, David C ^a   Williams, Thomas N ^b,c   Gladwin, Mark T ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ACETYLCYSTEINE; BOSENTAN; BUTYRIC ACID; DEXAMETHASONE; DIPYRIDAMOLE; FINASTERIDE; GLUTAMINE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYDROXYUREA; LENALIDOMIDE; PHOSPHODIESTERASE V INHIBITOR; POMALIDOMIDE; SALAZOSULFAPYRIDINE; SILDENAFIL; VARESPLADIB;

ACUTE CHEST SYNDROME; BACTERIAL INFECTION; BLOOD TRANSFUSION; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISEASE SEVERITY; GENE TRANSFER; HEART DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IRON CHELATION; KIDNEY DISEASE; NEUROLOGIC DISEASE; PAIN; PATHOPHYSIOLOGY; PRENATAL DIAGNOSIS; PRIAPISM; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SICKLE CELL ANEMIA; UNSPECIFIED SIDE EFFECT;

EID: 78650179046     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61029-X     Document Type: Conference Paper

References (150)

1. D Weatherall, K Hofman, G Rodgers, J Ruffin, S Hrynkow A case for developing North-South partnerships for research in sickle cell disease Blood 105 2005 921 923
2. JB Herrick Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia Arch Intern Med 6 1910 517 521
3. VP Sydenstricker Further observations on sickle cell anemia J Am Med Ass 83 1924 12 15
4. GS Graham Case of sickle cell anaemia with necropsy Arch Intern Med 34 1924 778 800
5. L Pauling, HA Itano, SJ Singer, IC Wells Sickle cell anemia, a molecular disease Science 110 1949 543 548
6. J Watson, AW Staham, FP Billelo The significance of the paucity of sickle cells in newborn negro infants Am J Med Sci 215 1948 419 423
7. MF Perutz, AM Liquori, F Eirich X-ray and solubility studies of the haemoglobin of sickle-cell anaemia patients Nature 167 1951 929 931
8. AB John, A Ramlal, H Jackson, GH Maude, AW Sharma, GR Serjeant Prevention of pneumococcal infection in children with homozygous sickle cell disease BMJ 26 1984 1567 1570
9. MH Gaston, JL Verter, G Woods Prophylaxis with oral penicillin in children with sickle cell anemia N Engl J Med 314 1986 1593 1599
10. FL Johnson, AT Look, J Gockerman, MR Ruggiero, L Dalla-Pozza, FT Billings 3rd Bone-marrow transplantation in a patient with sickle-cell anemia N Engl J Med 311 1984 780 783
11. S Charache, ML Terrin, RD Moore Effect of hydroxyurea on frequency of painful crises in sickle cell anemia N Engl J Med 332 1995 1317 1322
12. RJ Adams, VC McKie, L Hsu Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography N Engl J Med 339 1998 5 11
13. RL Nagel, ME Fabry, MH Steinberg The paradox of hemoglobin SC disease Blood Rev 17 2003 167 178
14. GR Serjeant, BE Serjeant Sickle cell disease 2001 Oxford University Press Oxford, UK
15. W Moo-Penn, K Bechtel, D Jue The presence of hemoglobin S and C Harlem in an individual in the United States Blood 46 1975 363 367
16. N Monplaisir, G Merault, C Poyart Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes Proc Natl Acad Sci USA 83 1986 9363 9367
17. HE Witkowska, BH Lubin, Y Beuzard Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-Chori N Engl J Med 325 1991 1150 1154
18. RL Nagel, S Daar, JR Romero HbS-Oman heterozygote: a new dominant sickle syndrome Blood 92 1998 4375 4382
19. D Masiello, MM Heeney, AH Adewoye Hemoglobin SE disease - a concise review Am J Haematol 82 2007 643 649
20. A Geva, JJ Clark, Y Zhang, A Popowicz, JM Manning, EJ Neufeld Hemoglobin Jamaica Plain - a sickling hemoglobin with reduced oxygen affinity N Engl J Med 351 2004 1532 1538
21. HF Bunn Pathogenesis and treatment of sickle cell disease N Engl J Med 337 1997 762 769
22. GM Brittenham, AN Schechter, CT Noguchi Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes Blood 65 1985 183 189
23. CT Noguchi, GP Rodgers, G Serjeant, AN Schechter Levels of fetal hemoglobin necessary for treatment of sickle cell disease N Engl J Med 318 1988 96 99
24. PS Frenette Sickle cell vaso-occlusion: multistep and multicellular paradigm Curr Opin Hematol 9 2002 101 106
25. A Turhan, LA Weiss, N Mohandas, BS Coller, PS Frenette Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm Proc Natl Acad Sci USA 99 2002 3047 3051
26. JD Belcher, CJ Bryant, J Nguyen Transgenic sickle mice have vascular inflammation Blood 101 2003 3953 3959
27. UR Osarogiagbon, S Choong, JD Belcher, GM Vercellotti, MS Paller, RP Hebbel Reperfusion injury pathophysiology in sickle transgenic mice Blood 96 2000 314 320
28. KC Wood, RP Hebbel, DN Granger Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice Faseb J 19 2005 989 991
29. JD Belcher, H Mahaseth, TE Welch Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice Am J Physiol Heart Circ Physiol 288 2005 H2715 H2725
30. OS Platt, DJ Brambilla, WF Rosse Mortality in sickle cell disease. Life expectancy and risk factors for early death N Engl J Med 330 1994 1639 1644
31. CH Pegelow, L Colangelo, M Steinberg Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia Am J Med 102 1997 171 177
32. K Ohene-Frempong, SJ Weiner, LA Sleeper Cerebrovascular accidents in sickle cell disease: rates and risk factors Blood 91 1998 288 294
33. MT Gladwin, V Sachdev, ML Jison Pulmonary hypertension as a risk factor for death in patients with sickle cell disease N Engl J Med 350 2004 886 895
34. GJ Kato, M Hsieh, R Machado Cerebrovascular disease associated with sickle cell pulmonary hypertension Am J Hematol 81 2006 503 510
35. GJ Kato, MT Gladwin, MH Steinberg Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes Blood Rev 21 2007 37 47
36. LM De Castro, JC Jonassaint, FL Graham, A Ashley-Koch, MJ Telen Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes Am J Hematol 83 2008 19 25
37. KI Ataga, CG Moore, S Jones Pulmonary hypertension in patients with sickle cell disease: a longitudinal study Br J Haematol 134 2006 109 115
38. N Dham, G Ensing, C Minniti Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease Am J Cardiol 104 2009 713 720
39. CP Minniti, C Sable, A Campbell Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation Haematologica 94 2009 340 347
40. RP Rother, L Bell, P Hillmen, MT Gladwin The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease JAMA 293 2005 1653 1662
41. T Repka, RP Hebbel Hydroxyl radical formation by sickle erythrocyte membranes: role of pathologic iron deposits and cytoplasmic reducing agents Blood 78 1991 2753 2758
42. CD Reiter, X Wang, JE Tanus-Santos Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease Nat Med 8 2002 1383 1389
43. RM Palmer, DS Ashton, S Moncada Vascular endothelial cells synthesize nitric oxide from L-arginine Nature 333 1988 664 666
44. R De Caterina, P Libby, HB Peng Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines J Clin Invest 96 1995 60 68
45. MT Gladwin Deconstructing endothelial dysfunction: soluble guanylyl cyclase oxidation and the NO resistance syndrome J Clin Invest 116 2006 2330 2332
46. CR Morris, GJ Kato, M Poljakovic Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease JAMA 294 2005 81 90
47. KI Ataga, CG Moore, CA Hillery Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension Haematologica 93 2008 20 26
48. M Westerman, A Pizzey, J Hirschman Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy Br J Haematol 142 2008 126 135
49. J Flint, RM Harding, AJ Boyce, JB Clegg The population genetics of the haemoglobinopathies Baillieres Clin Haematol 11 1998 1 51
50. AC Allison Protection afforded by sickle cell trait against subtertian malarial infection BMJ 1 1954 290 295
51. LL Cavalli-Sforza, P Menozzi, A Piazza The history and geography of human genes 1994 Princeton University Press New Jersey, USA 1088
52. B Modell, M Darlison Global epidemiology of haemoglobin disorders and derived service indicators Bull World Health Organ 86 2008 480 487
53. AJ Lysenko, IN Semashko Geography of malaria. A medico-geographic profile of an ancient disease [in Russian] AW Lebedew 1968 Academy of Science Moscow, Russia 25 146 Itogi Nauki: Medicinskaja Geografija.
54. SI Hay, CA Guerra, AJ Tatem, AM Noor, RW Snow The global distribution and population at risk of malaria: past, present, and future Lancet Infect Dis 4 2004 327 336
55. TN Williams, TW Mwangi, S Wambua Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases J Infect Dis 192 2005 178 186
56. J May, JA Evans, C Timmann Hemoglobin variants and disease manifestations in severe falciparum malaria JAMA 297 2007 2220 2226
57. TE Wellems, K Hayton, RM Fairhurst The impact of malaria parasitism: from corpuscles to communities J Clin Invest 119 2009 2496 2505
58. GR Serjeant Mortality from sickle cell disease in Africa BMJ 330 2005 432 433
59. J Makani, TN Williams, K Marsh Sickle cell disease in Africa: burden and research priorities Ann Trop Med Parasitol 101 2007 3 14
60. MC Rahimy, A Gangbo, G Ahouignan Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting Blood 102 2003 834 838
61. TN Williams, S Uyoga, A Macharia Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study Lancet 374 2009 1364 1370
62. TV Adamkiewicz, S Sarnaik, GR Buchanan Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination J Pediatr 143 2003 438 444
63. O Oniyangi, AA Omari Malaria chemoprophylaxis in sickle cell disease Cochrane Database Syst Rev 4 2006 CD003489.
64. J Makani, AN Komba, SE Cox Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization Blood 115 2010 215 220
65. CM McAuley, C Webb, J Makani High mortality from P. falciparum in children living with sickle cell anemia on the coast of Kenya Blood 116 2010 1663 1668
66. M Garenne, E Gakusi Health transitions in sub-Saharan Africa: overview of mortality trends in children under 5 years old (1950-2000) Bull World Health Organ 84 2006 470 478
67. BJ Bain Neonatal/newborn haemoglobinopathy screening in Europe and Africa J Clin Pathol 62 2009 53 56
68. OS Platt, BD Thorington, DJ Brambilla Pain in sickle cell disease. Rates and risk factors N Engl J Med 325 1991 11 16
69. M Koshy, R Entsuah, A Koranda Leg ulcers in patients with sickle cell disease Blood 74 1989 1403 1408
70. Gγ globin production Blood 66 1985 1463 1465
71. SL Thein, S Menzel, X Peng Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults Proc Natl Acad Sci USA 104 2007 11346 11351
72. S Menzel, C Garner, I Gut A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15 Nat Genet 39 2007 1197 1199
73. G Lettre, VG Sankaran, MA Bezerra DNA polymorphisms at the BCL11A, HBS1L-MYB and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease Proc Natl Acad Sci USA 105 2008 11869 11874
74. DR Higgs, BE Aldridge, J Lamb The interaction of alpha thalassaemia and homozygous sickle-cell disease N Engl J Med 306 1982 1441 1446
75. BC Kar, RK Satapathy, AE Kulozik Sickle cell disease in Orissa State, India Lancet 2 1986 1198 1201
76. MA Padmos, GT Roberts, K Sackey Two different forms of homozygous sickle cell disease occur in Saudi Arabia Br J Haematol 79 1991 93 98
77. F Bernaudin, S Verlhac, S Chevret G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia Blood 114 2009 742 743
78. N Vasavda, S Menzel, S Kondaveeti The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease Br J Haematol 138 2007 263 270
79. VG Nolan, DF Wyszynski, LA Farrer, MH Steinberg Hemolysis-associated priapism in sickle cell disease Blood 106 2005 3264 3267
80. FM Gill, LA Sleeper, SJ Weiner Clinical events in the first decade in a cohort of infants with sickle cell disease Blood 86 1995 776 783
81. C Hoppe, W Klitz, K D'Harlingue Confirmation of an association between TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia Stroke 38 2007 2241 2246
82. C Hoppe, W Klitz, S Cheng Gene interactions and stroke risk in children with sickle cell anemia Blood 103 2004 2391 2396
83. P Sebastiani, MF Ramoni, V Nolan, CT Baldwin, MH Steinberg Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia Nat Genet 37 2005 340 341
84. MH Steinberg, AB Adewoye Modifier genes and sickle cell anemia Curr Opin Hematol 13 2006 131 136
85. AM Redwood, EM Williams, P Desai, GR Serjeant Climate and painful crisis of sickle-cell disease in Jamaica BMJ 1 1976 66 68
86. S Jones, ER Duncan, N Thomas Windy weather and low humidity are associated with an increased number of hospital admissions for acute pain and sickle cell disease in an urban environment with a maritime temperate climate Br J Haematol 131 2005 530 533
87. D Yallop, ER Duncan, E Norris The associations between air quality and the number of hospital admissions for acute pain and sickle-cell disease in an urban environment Br J Haematol 136 2007 844 848
88. H Mittal, L Roberts, GW Fuller The effects of air quality on haematological and clinical parameters in children with sickle cell anaemia Ann Hematol 88 2009 529 533
89. K Ryan, B Bain, D Worthington Significant haemoglobinopathies: guidelines for screening and diagnosis Br J Haematol 149 2010 35 49
90. V Vichinsky, D Hurst, A Earles, K Kleman, B Lubin Newborn screening for sickle cell disease: effect on mortality Pediatrics 81 1988 749 755
91. OS Platt, SH Orkin, G Dover, GP Beardsley, B Miller, DG Nathan Hydroxyurea enhances fetal hemoglobin production in sickle cell anaemia J Clin Invest 74 1984 652 656
92. J-P Cartron, J Elion Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea Transfus Clin Biol 15 2008 39 50
93. TF Lou, M Singh, A Mackie, W Li, BS Pace Hydroxyurea generates nitric oxide in human erythroid cells: mechanisms for gamma-globin gene activation Exp Biol Med 234 2009 1374 1382
94. JJ Strouse, S Lanzkron, MC Beach Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children Pediatrics 122 2008 1332 1342
95. S Lankron, JJ Stouse, R Wilson Systematic review: hydroxyurea for the treatment of adults with sickle cell disease Ann Intern Med 48 2008 939 955
96. I Berthaut, G Guignedoux, F Kirsch-Noir Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males Hematologica 93 2008 988 993
97. SK Ballas, WF McCarthy, N Guo Exposure to hydroxyurea and pregnancy outcomes in sickle cell anemia J Natl Med Assoc 101 2009 1046 1051
98. MH Steinberg, F Barton, O Castro Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment JAMA 289 2003 1645 1651
99. E Voskaridou, D Christoulas, A Bilalis The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS) Blood 115 2010 2354 2363
100. SA Zimmerman, WH Schultz, S Burgett, NA Mortier, RE Ware Hydroxyurea therapy lowers transcranial doppler flow velocities in children with sickle cell anemia Blood 110 2007 1043 1047
101. SA Singh, AC Koumbourlis, B Aygun Resolution of chronic hypoxemia in pediatric sickle cell patients after treatment with hydroxyurea Pediatr Blood Cancer 50 2008 1258 1260
102. CD Fitzhugh, DR Wigfall, RE Ware Enalapril and hydroxyurea therapy for children with sickle nephropathy Pediatr Blood Cancer 45 2005 982 985
103. OW Brawley, LJ Cornelius, LR Edwards National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease Ann Intern Med. 148 2008 932 938
104. JR Eckman Techniques for blood administration in sickle cell patients Semin Hematol 38 2001 23 29
105. EP Vichinsky, A Earles, RA Johnson Alloimmunization in sickle cell anaemia and transfusion of racially unmatched blood N Engl J Med 322 1990 1617 1621
106. JC Wood, JM Tyszka, S Carson, MD Nelson, TD Coates Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease Blood 103 2004 1934 1936
107. E Vichinsky, O Onyekwere, JB Porter A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease Br J Haematol 136 2007 501 508
108. M Bhatia, MC Walters Hematopoietic cell transplantation for thalassaemia and sickle cell disease: past, present and future Bone Marrow Transplant 41 2008 109 117
109. MM Hsieh, EM Kang, CD Fitzhugh Allogeneic hematopoietic stem-cell transplantation for sickle cell disease N Engl J Med 361 2009 2309 2317
110. R Pawliuk, KA Westerman, ME Fabry Correction of sickle cell disease in transgenic mouse models by gene therapy Science 294 2001 2368 2371
111. DA Persons Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders Hematology Am Soc Hematol Educ Program 2009 690 697
112. J Hanna, M Wernig, S Markoulaki Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin Science 318 2007 1920 1923
113. JJ Field, EA Macklin, Y Yan, RC Strunk, MR DeBaun Sibling history of asthma is a risk factor for pain in children with sickle cell anemia Am J Hematol 83 2008 855 857
114. DR Hargrave, A Wade, JP Evans, DK Hewes, FJ Kirkham Nocturnal oxygen saturation and painful sickle cell crises in children Blood 101 2003 846 848
115. P Bartolucci, T El Murr, F Roudot-Thoraval A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults Blood 114 2009 3742 3747
116. SJ Jacobson, BA Kopecky, P Joshi, N Babul Randomized trial of oral morphine for painful episodes of sickle-cell disease in children Lancet 350 1997 1358 1361
117. National Confidential Enquiry into Patient Outcome and Death A sickle crisis? A report of the National Confidential Enquiry Into Patient Outcome And Death http://www.ncepod.org.uk/2008report1/Downloads/Sickle-report.pdf 2008 (accessed Jan 4, 2010).
118. TC Griffin, D McIntire, GR Buchanan High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease N Engl J Med 330 1994 733 737
119. EP Orringer, JF Casella, KI Ataga Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: a randomized controlled trial JAMA 286 2001 2099 2106
120. DL Weiner, PL Hibberd, P Betit, AB Cooper, CA Botelho, C Brugnara Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease JAMA 289 2003 1136 1142
121. Anon Inhaled nitric oxide for pediatric painful sickle crisis http://clinicaltrials.gov/ct2/show/NCT00142051 Aug 27, 2009 (accessed Aug 17, 2010).
122. NB Halasa, SM Shankar, TR Talbot Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine Clin Infect Dis 44 2007 1428 1433
123. CR Deane, D Goss, J Bartram Extracranial internal carotid arterial disease in children with sickle cell anaemia Haematologica 95 2010 1287 1292
124. S O'Driscoll, SE Height, MC Dick, DC Rees Serum lactate dehydrogenase as a biomarker in children with sickle cell disease Br J Haematol 140 2008 206 209
125. JA Switzer, DC Hess, FT Nichols, RJ Adams Pathophysiology and treatment of stroke in sickle-cell disease: present and future Lancet Neurol 5 2006 501 512
126. I Prohovnik, A Hurlet-Jensen, R Adams, D De Vivo, SG Pavlakis Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease J Cereb Blood Flow Metab 29 2009 803 810
127. HJ Fullerton, RJ Adams, S Zhao, SC Johnston Declining stroke rates in Californian children with sickle cell disease Blood 104 2004 36 339
128. Anon Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) http://clinicaltrials.gov/ct2/show/NCT00122980 June 25, 2010 (accessed Aug 17, 2010).
129. LA Verduzco, DG Nathan Sickle cell disease and stroke Blood 114 2009 5117 5125
130. ER Smith, CD McClain, M Heeney, RM Scott Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome Neurosurg Focus 26 2009 1 8
131. JL Kwiatkowski, RA Zimmerman, AN Pollock Silent infarcts in young children with sickle cell disease Br J Haematol 146 2009 300 305
132. Anon Silent cerebral infarct multi-center clinical trial http://clinicaltrials.gov/ct2/show/NCT00072761 May 6, 2010 (accessed Aug 17, 2010).
133. AM Hogan, IM Pit-ten Cate, F Vargha-Khadem, M Prengler, FJ Kirkham Physiological correlates of intellectual function in children with sickle cell disease: hypoxaemia, hyperaemia and brain infarction Dev Sci 9 2006 379 387
134. MT Gladwin, E Vichinsky Pulmonary complications of sickle cell disease N Engl J Med 359 2008 2254 2265
135. EP Vichinsky, LD Neumayr, AN Earles Causes and outcomes of the acute chest syndrome in sickle cell disease N Engl J Med 342 2000 1855 1865
136. JC Bernini, ZR Rogers, ES Sandler, JS Reisch, CT Quinn, GR Buchanan Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease Blood 92 1998 3082 3089
137. RF Machado, MT Gladwin Pulmonary Complications of Hematological Disease RJ Murray VC Broaddus T Martin Murray and Nadel's Textbook of Respiratory Medicine 5th edn. 2010 Elsevier Philadelphia, PA 1999 2021
138. D Bachir, F Parent, L Hajji Prospective multicentric survey on pulmonary hypertension (PH) in adults with sickle cell disease Blood 114 2009 572
139. RF Machado, S Martyr, GJ Kato Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension Br J Haematol 130 2005 445 453
140. V Sachdev, RF Machado, Y Shizukuda Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease J Am Coll Cardiol 49 2007 472 479
141. A Mekontso Dessap, R Leon, A Habibi Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease Am J Respir Crit Care Med 177 2008 646 653
142. JI Scheinman Sickle cell disease and the kidney Nat Clin Pract Nephrol 5 2009 78 88
143. RE Ware, RC Rees, SA Sarnaik Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial J Pediatr 156 2010 66 70
144. LD Neumayr, C Aguilar, AN Earles Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment J Bone Joint Surg Am 88 2006 2573 2582
145. P Hernigou, G Daltro, P Filippini, MM Mukasa, O Manicom Percutaneous implantation of autologous bone marrow osteoprogenitor cells as treatment of bone avascular necrosis related to sickle cell disease Open Orthop J 2 2008 62 65
146. D Sayag, M Binaghi, EH Souied Retinal photocoagulation for proliferative sickle cell retinopathy: a prospective clinical trial with new sea fan classification Eur J Ophthalmol 18 2008 248 254
147. RC Siqueira, RA Costa, IU Scott, LP Cintra, R Jorge Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy Acta Ophthalmol Scand 84 2006 834 835
148. KL Mekeel, MR Langham Jr, R Gonzalez-Peralta, S Fujita, AW Hemming Liver transplantation in children with sickle-cell disease Liver Transpl 13 2007 505 508
149. D Rachid-Filho, AG Cavalcanti, LA Favorito, WS Costa, FJ Sampaio Treatment of recurrent priapism in sickle cell anemia with finasteride: a new approach Urology 74 2009 1054 1057
150. W Hagar, E Vichinsky Advances in clinical research in sickle cell disease Br J Haematol 141 2008 346 356